The goal of the Symposium is to assemble researchers who work in diverse viral systems yet share a common interest in mechanisms of antiviral drug action and resistance. The focus will be on specific molecular targets, their normal structure and function, their interactions with antiviral drugs, and the evolutionary basis and specific mechanisms of viral resistance. Hans-Georg Kr usslich, Clifford Lane, Charles M. Rice, Douglas Richman, and Christoph Seeger.
Further details are available at the Symposium web site .
The HIV Drug Resistance Program hosted the 2001 Think Tank Meeting on February 27 at the NCI-Frederick. This annual event brings together investigators from the NCI and NIH with research interests related to the Program's goals for an intense day of short presentations and discussion. Like the previous three meetings, this year's meeting was very successful at fostering collaborations among these investigators. Dr. Coffin currently serves as both Director of the HIV Drug Resistance Program, NCI, and American Cancer Society Research Professor at Tufts University School of Medicine. He was elected into the NAS one of the highest honors that can be conferred on any scientist in recognition of his many accomplishments in the fields of virology and molecular genetics, as well as the major role he has played in public policy issues concerning retroviral disease.